APA (7th ed.) Citation

GN, I., K, B., L, Y., Y, H., HM, L., D, B., . . . KL, B. (2025). Effectiveness of the 2024-2025 KP.2 COVID-19 vaccines in the United States during long-term follow-up. Nature communications, 17(1), 1043. https://doi.org/10.1038/s41467-025-67796-0

Chicago Style (17th ed.) Citation

GN, Ioannou, et al. "Effectiveness of the 2024-2025 KP.2 COVID-19 Vaccines in the United States During Long-term Follow-up." Nature Communications 17, no. 1 (2025): 1043. https://doi.org/10.1038/s41467-025-67796-0.

MLA (9th ed.) Citation

GN, Ioannou, et al. "Effectiveness of the 2024-2025 KP.2 COVID-19 Vaccines in the United States During Long-term Follow-up." Nature Communications, vol. 17, no. 1, 2025, p. 1043, https://doi.org/10.1038/s41467-025-67796-0.